HLS Therapeutics Inc (HLS) — Capital Reinvestment Ratio
Latest as of December 2025:
0.01x
HLS Therapeutics Inc (HLS) has a Capital Reinvestment Ratio of 0.01x as of December 2025, meaning it reinvests 0% of its operating cash flow (CA$6.44 Million) in capital expenditures (CA$33.45K). See HLS free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.01x
Capex / Operating Cash Flow
Operating Cash Flow
CA$6.44 Million
CAD
Capital Expenditures
CA$33.45K
CAD
Data as of
Dec 2025
Most recent filing
HLS Therapeutics Inc Capital Reinvestment Ratio (1996–2025)
This chart tracks HLS Therapeutics Inc's Capital Reinvestment Ratio across 27 annual periods.
Annual Capital Reinvestment Ratio for HLS Therapeutics Inc (1996–2025)
Year-by-year Capital Reinvestment Ratio for HLS Therapeutics Inc from 1996 to 2025. For live market cap and broader valuation context, see market cap of HLS Therapeutics Inc.
| Year | Reinvestment Ratio | Operating CF (CAD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.01x | CA$16.02 Million | CA$208.59K | ▲ +594.8% |
| 2024 | 0.00x | CA$8.00 Million | CA$15.00K | ▼ -84.3% |
| 2023 | 0.01x | CA$15.79 Million | CA$189.00K | ▼ -98.0% |
| 2022 | 0.60x | CA$16.94 Million | CA$10.15 Million | ▲ +118.2% |
| 2021 | 0.27x | CA$16.43 Million | CA$4.51 Million | ▼ -94.3% |
| 2020 | 4.78x | CA$9.34 Million | CA$44.68 Million | ▲ +4834.2% |
| 2019 | 0.10x | CA$26.41 Million | CA$2.56 Million | ▲ +306.3% |
| 2018 | 0.02x | CA$32.75 Million | CA$781.00K | ▲ +262.0% |
| 2017 | 0.01x | CA$27.17 Million | CA$179.00K | ▲ +190.2% |
| 2014 | 0.00x | CA$18.21 Million | CA$41.35K | ▼ -91.7% |
| 2013 | 0.03x | CA$18.03 Million | CA$491.19K | ▼ -71.4% |
| 2012 | 0.10x | CA$21.23 Million | CA$2.02 Million | ▼ -35.7% |
| 2011 | 0.15x | CA$17.92 Million | CA$2.66 Million | ▲ +29.3% |
| 2010 | 0.11x | CA$25.06 Million | CA$2.88 Million | ▼ -79.7% |
| 2009 | 0.56x | CA$5.32 Million | CA$3.00 Million | ▼ -70.4% |
| 2008 | 1.91x | CA$5.55 Million | CA$10.58 Million | ▲ +267.6% |
| 2007 | 0.52x | CA$21.98 Million | CA$11.39 Million | ▼ -98.0% |
| 2006 | 25.41x | CA$703.50K | CA$17.88 Million | ▲ +5769.7% |
| 2005 | 0.43x | CA$12.50 Million | CA$5.41 Million | ▼ -28.4% |
| 2004 | 0.60x | CA$2.49 Million | CA$1.50 Million | ▲ +80.6% |
| 2003 | 0.33x | CA$4.92 Million | CA$1.65 Million | ▲ +16.8% |
| 2002 | 0.29x | CA$7.01 Million | CA$2.01 Million | ▼ -28.4% |
| 2001 | 0.40x | CA$2.98 Million | CA$1.19 Million | ▲ +167.5% |
| 2000 | 0.15x | CA$6.59 Million | CA$985.21K | ▼ -88.9% |
| 1999 | 1.35x | CA$4.56 Million | CA$6.15 Million | ▲ +2.4% |
| 1997 | 1.32x | CA$5.52 Million | CA$7.27 Million | ▲ +210.5% |
| 1996 | 0.42x | CA$9.27 Million | CA$3.93 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow